Reports of a positive association between higher predicted neoantigen load and increased intratumoral lymphocyte infiltration (CD3+ and CD8+ T cells) and improved overall survival in colorectal, endometrial and ovarian cancer (169–171) led to studies addressing the relationship between neoantigen abundance and success of immune checkpoint blockade therapy in cancer. This evidence concerns the gene CD8A and ovarian carcinoma.